Nascent Biotech (OTCMKTS:NBIO) Stock Crosses Below Fifty Day Moving Average of $0.14

Share on StockTwits

Nascent Biotech Inc (OTCMKTS:NBIO)’s stock price passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $0.14 and traded as low as $0.11. Nascent Biotech shares last traded at $0.11, with a volume of 180,460 shares.

The company’s 50 day moving average price is $0.14 and its 200-day moving average price is $0.13.

About Nascent Biotech (OTCMKTS:NBIO)

Nascent Biotech, Inc, a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a monoclonal antibody to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as lung and breast cancer metastases to the brain; and pancreatic cancer.

Recommended Story: Should I follow buy, hold and sell recommendations?

Receive News & Ratings for Nascent Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nascent Biotech and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.